Connecting Small-Cap Companies With Hungry Investors
We specialize in helping emerging growth companies stand out in a noisy market. From strategic PR to targeted breakout alerts, we build awareness, attract new investors, and drive measurable traction.
3.50%
10.24%
0.65%
41.10%
36.47%
^GSPC 
DOW 
^NDX 
CCC3.HM 
BRK-B LIXT 
PDC Get Exclusive Alerts
Featured Sponsors
Vanderbilt Report Stocks & Crypto
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum arcu ipsum, faucibus id eleifend quis, lobortis efficitur ligula. Phasellus convallis ligula leo, consequat ullamcorper tortor placerat eget. Donec magna quam, aliquam at odio id, vulputate tristique...
Featured Stock Picks
Breakout Alerts
SNYR Stock Report
Dates: 1/26/2026 HEADLINE: Momentum Is Building — Here’s Why Traders Are Watching SNYR Now Small-cap momentum thrives on timing — and SNYR is entering a window traders look for.Recent trading action has pushed SNYR back onto active-watch lists as volume and price...
Worksport (WKSP) Update: New Manufacturing Scale, Product Launches, and Profitability Momentum Since Our November 2025 Report
When we last reviewed Worksport (NASDAQ: WKSP) in November 2025, the company was already showing clear signs of operational momentum — with rising revenues, expanding margins, and a growing dealer network supporting a cleaner, more diversified product roadmap. Since...
Breakout Alert: TC BioPharm (NASDAQ:TCBP)
Dates: 10/7/24 HEADLINE: “TC BioPharm (NASDAQ:TCBP): Cancer Treatment Patent Issued! Company Name: TC Biopharm Ticker: TCBP Exchange: NASDAQ Preview of Small Cap Exclusive's Research Report: Update 10/3/24 Since we released this research report we have seen gains of...
How We Can Help You
A Wide Array of Financial Services
We connect growth-focused companies and ambitious investors through a full suite of investor relations and marketing solutions. From awareness campaigns and PR strategy to targeted digital outreach, we help small-cap brands stand out and attract attention from the right audiences, delivering visibility, credibility, and measurable market momentum.
Investor Awareness Campaigns
Build visibility fast with tailored marketing strategies that put your stock on the radar of retail traders and microcap investors.
Breakout Stock Alerts
Leverage our proven email lists, PPC campaigns, and PR placements to reach engaged investors actively searching for the next big opportunity.
Digital & PPC Management
We manage investor-focused ad campaigns across Google, Facebook, and financial networks, driving qualified traffic to your stock story.
Media & PR Strategy
Amplify your message with press releases, analyst coverage, and financial media placement designed to position your company as the next breakout.
Market Reports & Financial News
GRDX Stock Review
Dates: 1/31/2026 Tech Grid Narrative + Volatility Attracts Trader Focus GridAI Technologies Corp. (NASDAQ: GRDX) has seen renewed interest from traders as themes around smart grid infrastructure and AI-driven energy optimization circulate across market narratives....
LIXT Stock Review
Dates: 1/31/2026 Momentum Rebuilds as Biotech Narrative Resurfaces LIXT has quietly worked its way back onto trader watchlists as recent activity suggests renewed interest following a volatile stretch. This LIXT Stock Review looks at how shifting sentiment,...
SNYR Stock Report
Dates: 1/26/2026 HEADLINE: Momentum Is Building — Here’s Why Traders Are Watching SNYR Now Small-cap momentum thrives on timing — and SNYR is entering a window traders look for.Recent trading action has pushed SNYR back onto active-watch lists as volume and price...
A Micropatch. A Urology Pipeline. Why Medicus Pharma (NASDAQ: MDCX) Keeps Leveling Up in 2025
October 7th, 2025 When we first spotlighted Medicus Pharma (MDCX), it was for one simple reason: the story had multiple ways to win. A non-invasive microneedle patch for skin cancer. A late-stage urology asset aiming squarely at two multibillion-dollar markets. And...
Angkor Resources: Balancing Profits with Stewardship in Cambodia and Canada
September 19th, 2025 2:30 pm ET In a world where resource companies are often judged solely by quarterly production numbers, Angkor Resources (TSX-V: ANK) (OTC:ANKOF) is carving a different path — one that fuses exploration upside with a deep respect for the...
Worksport (WKSP): From Record Sales to Clean-Energy Blueprint — Why 2025 Might Be the Year
September 13th, 2025 11:30 am ET If you’re looking for a small-cap with momentum, improving fundamentals, and multiple upcoming catalysts, Worksport (NASDAQ: WKSP) is shaping up as one of the most compelling under-radar stories in clean-tech & automotive...
A Micropatch. A Urology Pipeline. Why Medicus Pharma (NASDAQ:MDCX) Could Be the Biotech Story of the Year
September 7th, 2025 1:30 pm ET A Tiny Company Taking Aim at a Massive Problem There’s a shift stirring in small-cap biotech—and it’s not just in the laboratories. Medicus Pharma has quietly assembled a platform packed with near-term catalysts, novel technology, and...
Klotho Neurosciences (KLTO): The Forgotten Protein That Could Rewrite Neurodegeneration
Most investors are hypnotized by AI charts and EV headlines. But here’s the truth nobody likes to admit: the biggest risk isn’t missing the next tech boom. It’s losing your mind—or your body—to diseases like ALS, Alzheimer’s, or Parkinson’s. And that’s where a...
While the World Focuses on AI and Semiconductors, This Tiny Graphene Innovator Just Secured a Deal That Could Reinvent Global Infrastructure
Ticker: Argo Graphene Solutions (OTCQB: ARLSF | CSE: ARGO) Most investors are looking up — chasing sky-high valuations in semiconductors, electric vehicles, and biotech. But the real transformation could be happening under our feet. That’s because Argo Graphene...
While Big Pharma Chases the Obvious, One Tiny NASDAQ Biotech Is Quietly Advancing a Potential Breakthrough in ALS and Human Longevity
Most biotech headlines today follow a familiar script: weight-loss drugs, cancer immunotherapies, and the latest Big Pharma acquisitions. But transformational wealth doesn’t come from chasing what’s already priced in. It comes from spotting paradigm shifts before...